Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
breast-cancer
cyp2d6 polymorphism, ovarian function suppression/ablation, breast cancer, exemestane, tamoxifen, cyp2d6*10 mutations, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 890396
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.